Solid Biosciences Inc. ($SLDB)
Filing Information
| Accession Number | 0001193125-26-034083 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 3, 2026 |
| Document Date | Jan 29, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
513,679
Total Value
$182,389.56
P&L
+inf% (+$2,215,744.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 29, 2026 | Exercise/Conversion | 58,847 | โ | โ | 96,818 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 31, 2026 | Exercise/Conversion | 28,225 | โ | โ | 125,043 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 2, 2026 | Sale | 28,335 | $6.44 | $182,389.56 | 96,708 | Direct | โ | View Details | |
Chief Medical Officer | Performance Stock Units | Derivative | Jan 29, 2026 | Exercise/Conversion | 58,847 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Employee Stock Option (Right to Buy) | Derivative | Jan 29, 2026 | Grant/Award | 207,450 | $0.00 | $0.00 | 207,450 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Units | Derivative | Jan 29, 2026 | Grant/Award | 103,750 | $0.00 | $0.00 | 103,750 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Units | Derivative | Jan 31, 2026 | Exercise/Conversion | 28,225 | $0.00 | $0.00 | 84,675 | Direct | โ | View Details |